Hang Yin
Researcher Next ID · RN-027554
Researcher · Immunology and Microbiology
Ithaca, Malaysia
- Works count
- 413
- Citation count
- 28,930
- H-index
- 70
- i10-index
- 221
Research interests
Publications
Magnetic sensitivity of cryptochrome 4 from a migratory songbird
Nature · 2021 · https://doi.org/10.1038/s41586-021-03618-9
SARS-CoV-2 spike protein interacts with and activates TLR41
Cell Research · 2021 · 10.1038/s41422-021-00495-9
Small-Molecule Modulators of Toll-like Receptors
Accounts of Chemical Research · 2020 · 10.1021/acs.accounts.9b00631
Biological membranes in EV biogenesis, stability, uptake, and cargo transfer: an ISEV position paper arising from the ISEV membranes and EVs workshop
Journal of Extracellular Vesicles · 2019 · 10.1080/20013078.2019.1684862
Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles
Stem Cells Translational Medicine · 2017 · 10.1002/sctm.17-0055
Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility
Journal of Extracellular Vesicles · 2017 · 10.1080/20013078.2017.1396823
Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation
Proceedings of the National Academy of Sciences · 2016 · https://doi.org/10.1073/pnas.1602070113
HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia
Cell Reports · 2016 · 10.1016/j.celrep.2016.09.076
Drugging Membrane Protein Interactions
Annual Review of Biomedical Engineering · 2016 · 10.1146/annurev-bioeng-092115-025322
A magnetic protein biocompass
Nature Materials · 2015 · 10.1038/nmat4484
DAT isn’t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling
Molecular Psychiatry · 2015 · 10.1038/mp.2014.177
Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders
Science Signaling · 2015 · 10.1126/scisignal.2005965
Pharmacological characterization of the opioid inactive isomers (+)‐naltrexone and (+)‐naloxone as antagonists of toll‐like receptor 4
British Journal of Pharmacology · 2015 · 10.1111/bph.13394
Exosomes and Microvesicles: Identification and Targeting By Particle Size and Lipid Chemical Probes
ChemBioChem · 2014 · 10.1002/cbic.201400043
Discovery of Small‐Molecule Inhibitors of the TLR1/TLR2 Complex
Angewandte Chemie International Edition · 2012 · 10.1002/anie.201204910
Morphine activates neuroinflammation in a manner parallel to endotoxin
Proceedings of the National Academy of Sciences · 2012 · https://doi.org/10.1073/pnas.1200130109
Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
Journal of Neuroscience · 2012 · 10.1523/jneurosci.0684-12.2012
Toll‐like receptor 4 in CNS pathologies
Journal of Neurochemistry · 2010 · 10.1111/j.1471-4159.2010.06736.x
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
Brain Behavior and Immunity · 2009 · https://doi.org/10.1016/j.bbi.2009.08.004
Computational Design of Peptides That Target Transmembrane Helices
Science · 2007 · 10.1126/science.1136782
Terphenyl-Based Bak BH3 α-Helical Proteomimetics as Low-Molecular-Weight Antagonists of Bcl-x L
Journal of the American Chemical Society · 2005 · 10.1021/ja050122x
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
Angewandte Chemie International Edition · 2005 · https://doi.org/10.1002/anie.200461786
Terphenyl‐Based Helical Mimetics That Disrupt the p53/HDM2 Interaction
Angewandte Chemie International Edition · 2005 · 10.1002/anie.200462316
Design and Application of an α‐Helix‐Mimetic Scaffold Based on an Oligoamide‐Foldamer Strategy: Antagonism of the Bak BH3/Bcl‐xL Complex
Angewandte Chemie International Edition · 2003 · 10.1002/anie.200390154
Development of a Potent Bcl-x L Antagonist Based on α-Helix Mimicry
Journal of the American Chemical Society · 2002 · 10.1021/ja026861k
Current projects
No projects listed.